Breaking News Instant updates and real-time market news.

GOOGL

Alphabet Class A

$1,194.54

6.45 (0.54%)

, GOOG

Alphabet

$1,191.50

7.84 (0.66%)

15:59
03/19/19
03/19
15:59
03/19/19
15:59

Stadia announcement positive for Google and game publishers, says Baird

Following Google's (GOOGL) announcement of details on it's cloud video game streaming platform, "Stadia," Baird analyst Colin Sebastian said he views the announcement as positive both for Google and for game publishers such as Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two (TTWO). The gaming platform has "impressive technical capabilities" and will support third-party game development, noted Sebastian, who added that he views the hiring of Jade Raymond as a sign Google sees significant long-term opportunity in digital entertainment.

GOOGL

Alphabet Class A

$1,194.54

6.45 (0.54%)

GOOG

Alphabet

$1,191.50

7.84 (0.66%)

ATVI

Activision Blizzard

$46.30

1.33 (2.96%)

EA

Electronic Arts

$97.30

-2.39 (-2.40%)

TTWO

Take-Two

$95.34

1.58 (1.69%)

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

GOOGL Alphabet Class A
$1,194.54

6.45 (0.54%)

03/07/19
MSCO
03/07/19
NO CHANGE
Target $300
MSCO
Overweight
Arista Networks price target raised to $300 from $265 at Morgan Stanley
Morgan Stanley analyst James Faucette said he has increased confidence in Arista Networks' (ANET) ability to beat consensus estimates as he believes Arista is likely to benefit from hyperscale customers' growth. Faucette explains that he sees Arista sales as most closely tied to hyperscale service revenue and he believes better than expected revenue at Microsoft (MSFT), Google (GOOGL) and Facebook (FB) will lead to better than expected buying of Arista gear. Given that view and his confidence, Faucette raised his price target on Arista shares to $300 from $265 and keeps an Overweight rating on the stock.
03/06/19
COWN
03/06/19
DOWNGRADE
Target $40
COWN
Underperform
TripAdvisor downgraded to Underperform on weak 2019 start at Cowen
As reported previously, Cowen analyst Kevin Kopelman downgraded TripAdvisor (TRIP) to Underperform from Market Perform. The analyst cited a weak start to 2019, expectations for weaker usage, and worries about younger age demos using Google (GOOG). He expects profit growth to slow to single digits by 2020 and thinks the stock's multiple should now be more in line with peers. Kopelman lowered his price target to $40 from $50 on TripAdvisor shares.
03/05/19
03/05/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) initiated with a Buy at Needham. 2. Lennox (LII) initiated with a Neutral at Goldman Sachs. 3. Aurora Cannabis (ACB) initiated with an Outperform at Cowen. 4. Floor & Decor (FND) initiated with an Outperform at Baird. 5. Gossamer Bio (GOSS) initiated with an Outperform at Evercore ISI and SVB Leerink, an Overweight at Barclays, and a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/05/19
RSBL
03/05/19
NO CHANGE
Target $212
RSBL
Buy
Rosenblatt sees low odds Facebook would be forced to spin off Instagram
Though it is possible a new task force announced last week by the FTC may consider unwinding consummated M&A by internet companies, presumably including Facebook (FB) and Instagram, Rosenblatt analyst Mark Zgutowicz sees a low probability of such a forced spinoff for two primary reasons. First, spinning off Instagram would not necessarily make the social media market more competitive. Second, it may be hard to prove how such a theoretical breakup would better protect user privacy. In such a scenario, he sees potential for 13% downside to Facebook shares if the company were to be forced to spinout Instagram due to the added costs of running two separate companies. Zgutowicz said he remains an aggressive buyer of Facebook shares, despite the FTC task force that appears directed at mega cap tech companies including it, Google (GOOGL) and Amazon (AMZN), given the social media company's stable fundamentals and an accelerating earnings growth profile. Zgutowicz keeps a Buy rating and $212 price target on Facebook.
GOOG Alphabet
$1,191.50

7.84 (0.66%)

ATVI Activision Blizzard
$46.30

1.33 (2.96%)

02/19/19
STFL
02/19/19
NO CHANGE
Target $52
STFL
Buy
Activision Blizzard price target lowered to $52 from $57 at Stifel
Stifel analyst Drew Crum lowered his estimates for Activision Blizzard to reflect more conservative assumptions following the company's mixed Q4 results and weaker than expected 2019 guidance. However, he sees the announced restructuring as necessary and continues to favor the stock for the longer-term. Crum keeps a Buy rating on the shares, but trimmed his price target for Activision Blizzard to $52 from $57.
02/15/19
BMOC
02/15/19
NO CHANGE
Target $40
BMOC
Market Perform
Activision Blizzard price target lowered to $40 from $52 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Activision Blizzard to $40 and kept his Market Perform rating after its significantly-below-consensus FY19 guidance. The analyst notes that while the market was prepared for a weak guide, a wide restructuring plan, and cost reductions through job cuts, he sees the company faced with persisting challenges exacerbated by "a sparse release slate and demoralized workforce." Johnson recommends that investors "resist the urge to call this a bottom" after the stock was bid up by over 10% from this week's low above $45 per share.
03/15/19
PIPR
03/15/19
NO CHANGE
Target $52
PIPR
Overweight
Activision worth a look after 50% drop in six months, says Piper Jaffray
Activision Blizzard shares are down nearly 50% in the past six months and investors should be "kicking the tires," given an improving setup in late 2019 and 2020, Piper Jaffray analyst Michael Olson tells investors in a research note. The analyst sees five reasons to do the work on Activision, including: increasing near-term talk on streaming, potential E3 announcements, anticipation around improving fundamentals in 2020, management's re-allocation of resources towards key franchises, and valuation. While it may still be early with a lack of new game catalysts in 2019, patient investors should consider "chipping away at a position" in the stock at current levels, Olson writes. He maintains an Overweight rating on Activision Blizzard with a $52 price target.
03/19/19
MSCO
03/19/19
NO CHANGE
Target $55
MSCO
Overweight
Morgan Stanley lays out ways Call of Duty Mobile matters for Activision Blizzard
After Activision Blizzard announced that "Call of Duty: Mobile" will be launching in the Americas, Europe and elsewhere with a public beta coming this summer, Morgan Stanley analyst Brian Nowak listed four reasons he sees for why the game "matters." Namely, he sees CoD: Mobile as a way for the company to capitalize on its leading intellectual property in the rapidly growing free-to-play and mobile markets; he noted that there are multiple annual billion dollar revenue games in China alone, noting that even a $500M revenue mobile franchise would add 9% to 2020 EPS; he said he doesn't have the game in his model, meaning its "all optionatlity"; and he views the game as another opportunity to prove Call of Duty is still a AAA franchise. Nowak keeps an Overweight rating and $55 price target on Activision Blizzard shares.
EA Electronic Arts
$97.30

-2.39 (-2.40%)

03/04/19
BARD
03/04/19
NO CHANGE
Target $106
BARD
Outperform
EA's player growth momentum for Apex creates upside potential, says Baird
After Electronic Arts announced that Apex Legends had reached 50M players one month after launch, which is up from 25M players after the game's first week, Baird analyst Colin Sebastian said the sustained momentum in player growth gives estimates for the fourth quarter and fiscal year upside potential. Season 1 of Apex Legends, which will have a battle pass monetization strategy similar in structure to Fortnite's, is rumored to begin in mid-March, but no official announcement has been made, noted Sebastian. He keeps an Outperform rating and $106 price target on EA shares.
02/21/19
PIPR
02/21/19
NO CHANGE
Target $111
PIPR
Overweight
Electronic Arts price target raised to $111 from $99 at Piper Jaffray
Piper Jaffray analyst Michael Olson raised his price target for Electronic Arts to $111 after his firm's surveys of greater than 600 gamers suggested a high level of purchase intent for Anthem. Additionally, YouTube trailer views for Anthem are "decidedly favorable," Olson tells investors in a research note. He's not calling for Anthem to be a "new mega-hit franchise" ahead its release tomorrow, but he believes the game has an opportunity to become a modestly sized addition to EA's lineup. Until the recent launch of Apex Legends, EA's challenges with non-sports releases have disappointed investors, the analyst points out. He maintains an Overweight rating on Electronic Arts.
03/07/19
RHCO
03/07/19
NO CHANGE
RHCO
Electronic Arts price target raised to $107 from $90 at SunTrust
SunTrust analyst Matthew Thornton raised his price target on Electronic Arts to $107 to reflect the findings of his latest survey of battle royale Apex players, adding $300M and $400M in FY20 and FY21 related revenue to his model. The analyst also keeps his Buy rating on the shares longer term, citing Electronic Arts' position amid the shift in gaming to digital esports along with its title pipeline and financial flexibility.
03/19/19
MSCO
03/19/19
NO CHANGE
Target $88
MSCO
Equal Weight
Electronic Arts price target raised to $88 from $80 at Morgan Stanley
Morgan Stanley analyst Brian Nowak updated his estimates for Electronic Arts to reflect Apex Legends' positive early traction ahead of the games planned launch of its first "season pass" on March 19. Nowak, who has a $375M basecase for revenue from Apex but also sees potential that Apex could contribute as much as $1.3B revenue in FY20, keeps an Equal Weight rating on EA until he sees evidence of a "Fortnite-like" bull-case playing out. Given his updated estimates, Nowak raised his price target on EA shares to $88 from $80.
TTWO Take-Two
$95.34

1.58 (1.69%)

02/12/19
BMOC
02/12/19
DOWNGRADE
BMOC
Underperform
Take-Two downgraded to Underperform from Market Perform at BMO Capital
02/12/19
02/12/19
DOWNGRADE
Target $80

Underperform
Take-Two downgraded to Underperform at BMO Capital on dissipating RDR2 'buzz'
As previously reported, BMO Capital analyst Gerrick Johnson downgraded Take-Two to Underperform from Market Perform and cut his price target to $80 from $119. The analyst notes that after a 2-year "hype machine" blast for its Red Dead Redemption 2 title and its "strong" premier, the buzz around the game has "dissipated markedly." Johnson is concerned that game engagement may lapse and the company's ability to monetize the release to "desired levels" may be pressured. The analyst adds that lackluster results by videogame companies have caught up with their high valuations, sending the sector down since the fall. and sees Take-Two as not being immune to the broader downturn.
02/12/19
02/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BHP Billiton (BHP) downgraded to Neutral from Buy at Goldman Sachs. 2. Gilead (GILD) downgraded to Neutral from Buy at Citi and to Market Perform from Outperform at Wells Fargo. 3. Cisco (CSCO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst James Faucette saying Cisco's multiple has meaningfully expanded over the past 1.5 years as estimates and expectations have built in a likely benefit from security-driven networking. 4. Take-Two (TTWO) downgraded to Underperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying that after a 2-year "hype machine" blast for its Red Dead Redemption 2 title and its "strong" premier, the buzz around the game has "dissipated markedly." 5. Fastenal (FAST) downgraded to Sector Weight from Overweight at KeyBanc with analyst Steve Barger saying he continues to view the company as a "best-in-class" distributor with a "sizable first-mover advantage" in OnSite and Vending, but he finds the stock's risk/reward as more balanced near his prior price target of $62. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/13/19
SPHN
02/13/19
NO CHANGE
Target $57
SPHN
Overweight
Activision Blizzard transition year creates buying opportunity, says Stephens
Stephens analyst Jeff Cohen noted that Activision Blizzard (ATVI), like peers Electronic Arts (EA) and Take-Two (TTWO), gave 2019 guidance that was significantly below consensus and framed it as a transition year. Cohen, who said he feels confident now is the time to be buying as 2019 should represent the trough of earnings power, lowered his price target on the shares to $57 from $65 but keeps an Overweight rating on Activision Blizzard shares.

TODAY'S FREE FLY STORIES

03:30
10/16/19
10/16
03:30
10/16/19
03:30
General news
FX Action: USD-CAD has found a footing »

FX Action: USD-CAD has…

03:10
10/16/19
10/16
03:10
10/16/19
03:10
General news
FX Update: The dollar majors have been trading narrowly »

FX Update: The dollar…

02:00
10/16/19
10/16
02:00
10/16/19
02:00
General news
U.S. Retail Sales Preview: »

U.S. Retail Sales…

01:50
10/16/19
10/16
01:50
10/16/19
01:50
General news
Asian Market Update: »

Asian Market Update:…

SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

, SPX

S&P 500

$0.00

(0.00%)

20:46
10/15/19
10/15
20:46
10/15/19
20:46
Periodicals
China may retaliate if U.S. Congress passes bill supporting Hong Kong protesters 

Report from Bloomberg.

SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$29.74

0.59 (2.02%)

, ABT

Abbott

$82.06

2.25 (2.82%)

20:25
10/15/19
10/15
20:25
10/15/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BAC

Bank of America

$29.74

0.59 (2.02%)

ABT

Abbott

$82.06

2.25 (2.82%)

USB

U.S. Bancorp

$53.73

0.47 (0.88%)

PNC

PNC Financial

$141.86

1.38 (0.98%)

BK

BNY Mellon

$44.37

0.47 (1.07%)

ALLY

Ally Financial

$32.03

0.68 (2.17%)

CMA

Comerica

$67.01

1.765 (2.71%)

FHN

First Horizon

$16.13

0.22 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 27

    Oct

  • 07

    Nov

  • 12

    Nov

RIO

Rio Tinto

$51.40

-0.43 (-0.83%)

20:17
10/15/19
10/15
20:17
10/15/19
20:17
Hot Stocks
Rio Tinto reports Q3 Pilbara iron ore output 87.3M tons, up 6% from last year »

Reports Q3 Pilbara iron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNTX

Gentex

$26.98

0.65 (2.47%)

20:16
10/15/19
10/15
20:16
10/15/19
20:16
Initiation
Gentex initiated at Guggenheim »

Gentex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 04

    Nov

VNE

Veoneer

$16.11

0.82 (5.36%)

20:16
10/15/19
10/15
20:16
10/15/19
20:16
Initiation
Veoneer initiated at Guggenheim »

Veoneer initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VC

Visteon

$82.45

0.63 (0.77%)

20:15
10/15/19
10/15
20:15
10/15/19
20:15
Initiation
Visteon initiated at Guggenheim »

Visteon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

DLPH

Delphi Technologies

$14.37

0.45 (3.23%)

20:14
10/15/19
10/15
20:14
10/15/19
20:14
Initiation
Delphi Technologies initiated at Guggenheim »

Delphi Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

BWA

BorgWarner

$37.74

0.68 (1.83%)

20:13
10/15/19
10/15
20:13
10/15/19
20:13
Initiation
BorgWarner initiated at Guggenheim »

BorgWarner initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

LEA

Lear

$121.75

3.94 (3.34%)

20:13
10/15/19
10/15
20:13
10/15/19
20:13
Initiation
Lear initiated at Guggenheim »

Lear initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 04

    Nov

  • 10

    Dec

  • 11

    Dec

DFIN

Donnelley Financial Solutions

$10.54

0.035 (0.33%)

20:12
10/15/19
10/15
20:12
10/15/19
20:12
Initiation
Donnelley Financial Solutions initiated at B. Riley FBR »

Donnelley Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.84

2.17 (1.66%)

, TEVA

Teva

$6.96

0.22 (3.26%)

19:17
10/15/19
10/15
19:17
10/15/19
19:17
Periodicals
As part of proposed settlement, Teva offers $15B of free drugs, Bloomberg says »

The report also notes…

JNJ

Johnson & Johnson

$132.84

2.17 (1.66%)

TEVA

Teva

$6.96

0.22 (3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 07

    Nov

WAFD

Washington Federal

$36.81

0.15 (0.41%)

19:04
10/15/19
10/15
19:04
10/15/19
19:04
Earnings
Washington Federal reports Q4 EPS 66c, consensus 65c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

INGR

Ingredion

$81.17

0.94 (1.17%)

19:01
10/15/19
10/15
19:01
10/15/19
19:01
Hot Stocks
Ingredion discloses malware affecting certain data centers »

Ingredion issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

19:01
10/15/19
10/15
19:01
10/15/19
19:01
Periodicals
Pelosi holds off on House vote over impeachment inquiry, Politico says »

House Speaker Nancy…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$14.40

0.02 (0.14%)

18:59
10/15/19
10/15
18:59
10/15/19
18:59
Hot Stocks
Petrobras signs charter contracts for two FPSO platforms »

Petrobras announced that …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

SNBR

Sleep Number

$46.69

0.48 (1.04%)

, UAL

United Airlines

$87.90

0.9 (1.03%)

18:58
10/15/19
10/15
18:58
10/15/19
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Sleep…

SNBR

Sleep Number

$46.69

0.48 (1.04%)

UAL

United Airlines

$87.90

0.9 (1.03%)

MCK

McKesson

$138.17

4.01 (2.99%)

ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

CAH

Cardinal Health

$47.93

1.16 (2.48%)

FULT

Fulton Financial

$15.90

0.19 (1.21%)

ETN

Eaton

$82.16

1.29 (1.60%)

SFIX

Stitch Fix

$20.83

-0.38 (-1.79%)

MGM

MGM Resorts

$27.87

-0.1 (-0.36%)

JBHT

J.B. Hunt

$111.65

1.985 (1.81%)

IBKR

Interactive Brokers

$47.43

0.26 (0.55%)

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

PRQR

ProQR Therapeutics

$6.21

-0.09 (-1.43%)

NTRA

Natera

$39.21

1.01 (2.64%)

PRNB

Principia Biopharma

$29.88

0.7 (2.40%)

X

U.S. Steel

$11.43

0.27 (2.42%)

ARCE

Arco Platform

$48.15

0.75 (1.58%)

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 18

    Oct

KKR

KKR

$26.79

0.67 (2.57%)

, DB

Deutsche Bank

$7.79

0.235 (3.11%)

18:21
10/15/19
10/15
18:21
10/15/19
18:21
Periodicals
KKR, partners cancel Latitude Financial IPO, Reuters reports »

KKR (KKR) and its…

KKR

KKR

$26.79

0.67 (2.57%)

DB

Deutsche Bank

$7.79

0.235 (3.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 29

    Oct

  • 04

    Nov

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

18:20
10/15/19
10/15
18:20
10/15/19
18:20
Hot Stocks
Breaking Hot Stocks news story on Tradeweb Markets »

Tradeweb Markets sees Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 18

    Oct

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

18:17
10/15/19
10/15
18:17
10/15/19
18:17
Syndicate
Tradeweb Markets files to sell 14.8M shares of Class A common stock »

Refinitiv will continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 18

    Oct

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

18:16
10/15/19
10/15
18:16
10/15/19
18:16
Earnings
Tradeweb Markets sees Q3 adjusted EPS 27c, consensus 25c »

Sees Q3 revenue $200.98M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 18

    Oct

EDIT

Editas Medicine

$20.30

0.48 (2.42%)

18:15
10/15/19
10/15
18:15
10/15/19
18:15
Hot Stocks
Editas Medicine, AskBio enter research collaboration over in vivo delivery »

Editas Medicine and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.